Lymphoma

Niktimvo was approved for adults and children with chronic, pretreated graft-versus-host disease.

One researcher explains the science behind Lymphir, recently approved by the FDA for relapsed/refractory cutaneous T-cell lymphoma.

From Patti Yasutake’s death from cancer to Olympic water polo player’s husband’s rare cancer diagnosis, here’s what’s happening in the oncology space this week.

When I started experiencing symptoms of an infection, I was worried that my follicular lymphoma had returned.

Lymphir, an immunotherapy, has been approved by the FDA to treat patients with relapsed or refractory cutaneous T-cell lymphoma.

From democratic Rep. Sheila Jackson Lee’s death from pancreatic cancer to the rock band, Widespread Panic, canceling shows due to their guitarist’s diagnosis, here’s what’s happening in the oncology space this week.

Treating patients with CAR-T cell therapy Breyanzi may change the paradigm for those with relapsed or refractory mantle cell lymphoma, an expert said.

Reduced doses of radiation were shown to be effective for some patients with indolent orbital B-cell lymphoma, researchers said.

After having SLL for 15 years, I won't let it define me — now, I'm working towards larger passions in my life.

After fully recovering from non-Hodgkin lymphoma, I’m ready to embark on my next chapter in life doing the things I love with the people I love.

I was told that after five years in remission, my cancer would be behind me. However, I was not told what life would be like after that milestone.

Having a check-up appointment without receiving any type of scan is good, but also scares me.

Dana Frost, a cancer survivor and grief advocate, said writing about survivors’ guilt and connecting with others feeling the same way was therapeutic.

From the lead singer of Heart’s cancer diagnosis and postponing their tour to Dick Vitale’s upcoming cancer surgery, here’s what’s going on in the cancer space this week.

More frequent immunoglobulin G testing was associated with a decreased risk of severe infections in patients with CLL and non-Hodgkin lymphoma.

Sometimes, laughter really is the best medicine, so I tried to maintain a sense of humor through my cancer treatments.

Although there are still cancer drugs in short supply, the chief medical officer at the NCCN explained that most patients will not get suboptimal care.

From Judge Frank Caprio opening up about his diagnosis of pancreatic cancer and treatment to an “Ink Master” star dying from testicular cancer, here’s what’s going on in the oncology space this week.

The Food and Drug Administration approved Epkinly, a bispecific T-cell engager, for certain patients with follicular lymphoma.

In children with T-lymphoblastic lymphoma, having an MRD status of less than 0.1% may lead to more time without their cancer worsening or coming back.

My oncologist said that having a supportive community during cancer is just as important as treatment and I could not agree more — it makes me thankful.

Patients with chronic lymphocytic leukemia or small lymphocytic lymphoma tended to be more likely to stay on treatment and experience fewer heart toxicities with Calquence or Brukinsa.

Staying positive while receiving cancer treatment for non-Hodgkin lymphoma helped me feel grateful for happy moments.

My experience with non-Hodgkin lymphoma taught me to be grateful for the people I love and who love me.

When my sister experienced nausea and vomiting during her Hodgkin lymphoma treatment, we tried alternatives that seemed to help.